CSPC Pharmaceutical Group Limited (CSPCY)

OTC Markets OTCPK Currently unchanged in today's trading session

1 member of Congress has disclosed 1 trade in CSPC Pharmaceutical Group Limited (CSPCY) via STOCK Act filings. The most recent disclosure was a purchase by Josh Gottheimer on 17 September 2021. Aggregate disclosed activity totals roughly $8K in purchases (midpoint estimates from bracketed disclosure amounts).

CSPC Pharmaceutical Group Limited is currently trading at $4.25, positioned at 49% of its 52-week range ($2.73 – $5.83).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$4.25
24h Change
0.00 (0.00%)
52 Week Range
$2.73$5.83
View on NASDAQ

CSPC Pharmaceutical Group Limited Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for CSPCY

Select to highlight on chart
1 transactions
Compliance: 100%
Josh Gottheimer17 Sept 202113 Oct 2021PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$12.29B

Volume

10.9K

Beta

0.87

P/E Ratio

21.27

Fundamentals

EPS

$0.20

Div. Yield

3.53%

Open

$4.27

Day Range

$4.25 — $4.53

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
OTC · USD
Country
CN
CEO
Lei Cai
IPO Date
2021-03-25

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, the Americas, Europe, and internationa...

Earnings

Next Report

Q1 2026

27 May

EPS Est.

Rev. Est.

$8B

Days Until

26

Recent Quarters

Q2 202525 Aug
EPS
Q1 202529 May
EPS
Q4 202428 Mar
EPS
Q3 202415 Nov
EPS
Q2 202421 Aug
EPS$0.03
Q1 202427 May
EPS$0.02
Q4 202320 Mar
EPS$0.02
Q3 202330 Dec
EPS$0.03
Q1 202330 Jun
EPS$0.02
Q4 202231 Mar
EPS$0.01
Q3 202230 Dec
EPS$0.03
Q1 202229 Jun
EPS$0.03
Q3 202130 Dec
EPS$0.03
Q1 202129 Jun
EPS$0.04
Q3 202030 Dec
EPS$0.04
Q1 202029 Jun
EPS$0.03
Q3 201930 Dec
EPS$0.02
Q1 201929 Jun
EPS$0.02
Q3 201831 Dec
EPS$0.01
Q2 201830 Sept
EPS$0.01
Q1 201830 Jun
EPS$0.01
Q4 201731 Mar
EPS$0.01
Q3 201731 Dec
EPS$0.01
Q2 201730 Sept
EPS$0.01
Q1 201730 Jun
EPS$0.01
Q4 201631 Mar
EPS$0.01
Q3 201631 Dec
EPS$0.01
Q2 201630 Sept
EPS$0.01
Q1 201630 Jun
EPS$0.01
Q4 201531 Mar
EPS$0.01
Q3 201531 Dec
EPS$0.01
Q2 201530 Sept
EPS$0.00
Q1 201530 Jun
EPS$0.00
Q4 201431 Mar
EPS$0.00
Q3 201431 Dec
EPS$0.00
Q2 201430 Sept
EPS$0.00
Q1 201430 Jun
EPS$0.00
Q4 201331 Mar
EPS$0.00
Q3 201331 Dec
EPS$0.00
Q2 201330 Sept
EPS$0.00
Q1 201330 Jun
EPS$0.00
Q4 201231 Mar
EPS$0.00
Q3 201231 Dec
EPS$0.00
Q2 201230 Sept
EPS$0.01
Q1 201230 Jun
EPS$0.01
Q4 201131 Mar
EPS$0.01
Q3 201131 Dec
EPS$0.01
Q2 201130 Sept
EPS$0.00
Q1 201130 Jun
EPS$0.00
Q4 201031 Mar
EPS$0.00
Q3 201031 Dec
EPS$0.00
Q2 201030 Sept
EPS$0.01
Q1 201030 Jun
EPS$0.01
Q4 200931 Mar
EPS$0.01
Q3 200931 Dec
EPS$0.01
Q2 200930 Sept
EPS$0.01
Q1 200930 Jun
EPS$0.01
Q4 200831 Mar
EPS$0.01
Q4 200831 Jan
EPS$0.01
Q2 200830 Sept
EPS$0.01
Q1 200830 Jun
EPS$0.01
Q4 200731 Mar
EPS$0.01
Q4 200731 Jan
EPS$0.01
Q2 200730 Sept
EPS$0.00
Q1 200730 Jun
EPS$0.00
Q4 200631 Mar
EPS$0.00
Q4 200631 Jan
EPS$0.00
Q2 200630 Sept
EPS$0.00
Q1 200630 Jun
EPS$0.00
Q4 200531 Mar
EPS$0.00
Q4 200531 Jan
EPS$0.00
Q2 200530 Sept
EPS$0.00
Q1 200530 Jun
EPS$0.00
Q4 200431 Mar
EPS$0.00
Q4 200431 Jan
EPS$0.00
Q2 200430 Sept
EPS$0.00
Q1 200430 Jun
EPS$0.00
Q4 200331 Mar
EPS$0.00
Q4 200331 Jan
EPS$0.00
Q2 200330 Sept
EPS$0.01
Q1 200330 Jun
EPS$0.01
Q4 200231 Mar
EPS$0.01
Q4 200231 Jan
EPS$0.01

Dividends

Next Dividend

Ex-Date

25 Jun 2026

Amount

$0.0614 per share

Yield

2.90%

Days Until

55

Pay Date:29 Jul 2026
Record Date:25 Jun 2026

Dividend History

20 Oct 2025
Amount $0.0718
5 Jun 2025
Amount $0.0514
1 Nov 2024
Amount $0.0821
3 Jun 2024
Amount $0.0716
7 Sept 2023
Amount $0.0710
5 Jun 2023
Amount $0.0560
8 Sept 2022
Amount $0.0510
31 May 2022
Amount $0.0510
10 Sept 2021
Amount $0.0410
24 May 2021
Amount $0.0460
9 Sept 2020
Amount $0.0155
18 Jun 2020
Amount $0.0433
29 May 2019
Amount $0.0384

Stock Splits

Split History

10 Dec 2020Stock Split
Ratio8:5
7 Jul 2020Stock Split
Ratio6:5

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

NVDA

NVIDIA Corporation

20
$199.57-9.68 (-4.63%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

GOOG

Alphabet Inc.

17
$381.94+34.63 (+9.97%)
Communication Services
Held by same politician
1 politician
View Stock

PTSNX

PIMCO Short Term I-3

17
$9.69+0.01 (+0.10%)
Held by same politician
1 politician
View Stock

Frequently Asked Questions about CSPCY

Which members of Congress have traded CSPCY?
1 member of Congress has disclosed 1 trade in CSPC Pharmaceutical Group Limited (CSPCY) under the STOCK Act: Josh Gottheimer.
When was CSPCY most recently disclosed by Congress?
The most recent CSPCY disclosure was a purchase by Josh Gottheimer on 17 September 2021.
What is the total disclosed congressional trading volume for CSPCY?
Members of Congress have disclosed approximately $8K in CSPCY purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in CSPCY?
This CSPCY page updates as soon as new STOCK Act disclosures are filed for CSPC Pharmaceutical Group Limited. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi TrackerJoin our Discord
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.